Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

Erika L. Spaeth, Jennifer L. Dembinski, A. Kate Sasser et al. · 2009

Read Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression by Erika L. Spaeth, Jennifer L. Dembinski, A. Kate Sasser et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004992.txt.

Introduction

Tumors do not grow alone. They recruit support cells called fibroblasts. Erika Spaeth and colleagues traced where those fibroblasts come from. Their PLOS ONE paper appeared in 2009. They followed mesenchymal stem cells near tumors. The stem cells transition into tumor-associated fibroblasts.

The converted fibroblasts help build the tumor's fibrovascular network. That network supports further tumor progression. The study shows cancers drafting the body's repair cells into service. Blocking the transition could starve tumors of support. The finding identifies a fresh point of attack. It targets the tumor's neighborhood rather than the tumor itself.

Catalog record

CREATORErika L. Spaeth, Jennifer L. Dembinski, A. Kate Sasser et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004992

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression Authors: Erika L. Spaeth, Jennifer L. Dembinski, A. Kate Sasser, Keri Watson, Ann Klopp, Brett Hall, Michael Andreeff, Frank Marini Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0004992 ABSTRACT Tumor associated fibroblasts (TAF), are essential for tumor progression providing both a functional and structural supportive environment. TAF, known as activated fibroblasts, have an established biological impact on tumorigenesis as matrix synthesizing or matrix degrading cells, contractile cells, and even blood vessel associated cells. The production of growth factors, cytokines, chemokines, matrix-degrading enzymes, and immunomodulatory mechanisms by these cells augment tumor progression by providing a suitable environment. There are several suggested origins of the TAF including tissue-resident, circulating, and epithelial-to-mesenchymal-transitioned cells. We provide evidence that TAF are derived from mesenchymal stem cells (MSC) that acquire a TAF phenotype following exposure to or systemic recruitment into adenocarcinoma xenograft models including breast, pancreatic, and ovarian. We define the MSC derived TAF in a xenograft ovarian carcinoma model by the immunohistochemical presence of 1) fibroblast specific protein and fibroblast activated protein; 2) markers phenotypically associated with aggressiveness, including tenascin-c, thrombospondin-1, and stromelysin-1; 3) production of pro-tumorigenic growth factors including hepatocyte growth factor, epidermal growth factor, and interleukin-6; and 4) factors indicative of vascularization, including alpha-smooth muscle actin, desmin, and vascular endothelial growth factor. We demonstrate that under long-term tumor conditioning in vitro , MSC express TAF–like proteins. Additionally, human MSC but not murine MSC stimulated tumor growth primarily through the paracrine production of secreted IL6. Our results suggest the dependence of in vitro Skov-3 tumor cell proliferation is due to the presence of tumor-stimulated MSC secreted IL6. The subsequent TAF phenotype arises from the MSC which ultimately promotes tumor growth through the contribution of microvascularization, stromal networks, and the production of tumor-stimulating paracrine factors. INTRODUCTION Tumor cells are not self-sustaining entities, but interact via paracrine and juxtacrine signaling with the microenvironment. Among the cells found in this stromal environment are macrophages, endothelial cells, lymphocytes, fibroblasts, and pericytes which interact with tumor cells and the surrounding microenvironment through production of hormones, cytokines, chemokines and proteases. Tumors are thought to develop stroma from several sources, thus the characterization by Wels et al. of tumor-associated stromal cells as “migratory neighbors and distant invaders” [1] . Data in the literature currently support four origins: (1) the recruitment of resident tissue stem cells, (2) epithelial to mesenchymal transition of the tumor parenchyma, (3) fibroblast recruitment into the tumor stroma, and (4) recruitment of bone marrow-derived cells from the circulation [2] – [5] . We postulated that mesenchymal stem cells (MSC), like other bone marrow-resident cells, have the capacity to differentiate within the tumor microenvironment into fibroblastic-like cells that have been variably referred to as; myofibroblasts, tumor-associated (myo)fibroblasts (TAF), carcinoma-associated fibroblasts (CAF), fibrocytes or pericytes [6] . TAF have been shown to play an important role in tumor formation, growth and metastasis. The presence of fibroblast populations within human tumors is associated with poor outcome and an increase in metastatic potential [7] , [8] . These TAF are associated with expression of factors involved in degradation of matrix proteins, angiogenesis and promotion of cell growth: matrix metalloproteinases (MMP), plasminogen activator inhibitor-1, vascular endothelial growth factor (VEGF), insulin growth factor (IGF-2) and hepatocyte growth factor (HGF) [9] . The TAF population differs from a normal fibroblastic phenotype because of its rich source of tumor-growth-promoting factors, pro-angiogenic factors and expression of myofibroblastic characteristics. TAF are characterized by the presence of four qualifying factors: (1) fibroblast markers fibroblast-specific protein (FSP) and fibroblast activating protein (FAP); (2) genes associated with an increase of tumor aggression, including stromelysin-1 (SL-1), thrombospondin-1 (Tsp-1) and tenascin-C (Tn-C); (3) myofibroblast/provascularizing potential including desmin, alpha-smooth muscle actin (α-SMA), and vascular endothelial growth factor (VEGF) [10] ; and lastly, (4) growth factors, transforming growth factor-beta (TGF-β), HGF/scatter factor (SF), basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). MSC comprise a unique population of cells utilized for tissue maintenance and repair; their regenerative ability and multipotent capacity allow for their differentiation into osteocytes, adipocytes, chondrocytes, or myocytes. Importantly, MSC possess an innate tropism for injured tissue. Our group originally demonstrated the capacity of MSC, also known as multipotent stromal cells, to home to tumors and participate in tumor stroma formation, suggesting MSC as a potential source of stroma [11] , [12] . MSC are a heterogeneous population of connective tissues progenitors found in many locations, such as adipose tissue, dermis, and bone marrow. The tropism of MSC for tumors is thought to be due to similarity in factors secreted by wounds and tumors [13] , substantiating the concept that tumors are “wounds that never heal” [14] , [15] . It has been proposed that this tropism could be exploited by using MSC as gene-delivery vehicles for anticancer therapies, and this approach has shown promise in preclinical models [11] , [12] , [16] – [19] . The ability of MSC to travel to solid tumors after intravenous administration and their ability to develop myofibroblast-like characteristics under defined culture conditions [20] both suggest that TAF could be derived from MSC. Our study was designed to assess whether MSC are precursors of TAF-like cells in tumors and to analyze the contribution of MSC to the growth and development of tumor fibrovascular networks. We show herein the propensity of MSC to transition within a xenograft tumor model to TAF-like cells and, by immunohistochemical (IHC) staining, their tumor-supportive nature. In a murine tumor xenograft model, human tumors with admixed human MSC demonstrated cells expressing activated fibroblast-like markers including FAP, FSP, α-SMA, Tn-C, Tsp-1, desmin or SL-1, while tumors without admixed MSC did not show these markers. The presence of MSC within the tumor also enhanced expression of growth factors such as EGF and HGF. We further demonstrate that the microenvironment provided by the tumor stimulated MSC directly to enhance the growth of Skov-3, which is significantly enhanced by growth factors interleukin-6 (IL-6) and EGF. Our data suggest the involvement of the MSC as a component of tumor associated fibrovascular networks—this includes the pericytic population that contributes to the microvessel involved in the neovacularization as well as the fibroblastic population that contributes to matrix remodeling and tumor growth. To our knowledge is the first-in-kind report to demonstrate four levels of tumor support by MSC in the tumor microenvironment: 1) matrix formation, 2) growth factor production, 3) vasculogenesis/angiogenesis and 4) expression of proteins associated with tumor aggression. RESULTS The MSC population used in our investigation was characterized by flow cytometry and by western blot, prior to our in vivo analysis of the MSC. We were able to induce a TAF phenotype in vitro by conditioning MSC with Skov-3 conditioned medium over a period of 16 days. Naïve MSC expressed low levels of α-SMA, FAP and desmin and did not express the TAF markers FSP, TSP-1 or Tn-C ( Figure 1A ): they were positive for the MSC markers CD105, CD90, CD44, CD146, CD140b and CD166 and negative for hematopoietic and endothelial markers CD31, CD34 and CD45 ( Figure S1 ). Following 16 days of in vitro conditioning with Skov-3 cell medium the MSC express high levels of Tn-C, TSP and FSP and increased their

Read the complete text